Alleviatory effect of isoquercetin on benign prostatic hyperplasia via IGF-1/PI3K/Akt/mTOR pathway

We evaluated the effect of isoquercetin (quercetin-O-3-glucoside-quercetin, IQ) as a functional component of Abeliophyllum disistichum Nakai ethanol extract (ADLE) on prostate cell proliferation and apoptosis and its effects on the IGF-1/PI3K/Akt/mTOR pathway in benign prostatic hyperplasia (BPH). M...

Full description

Saved in:
Bibliographic Details
Main Authors: Young-Jin Choi, Meiqi Fan, Nishala Erandi Wedamulla, Yujiao Tang, Eun-Kyung Kim
Format: Article
Language:English
Published: Tsinghua University Press 2024-05-01
Series:Food Science and Human Wellness
Subjects:
Online Access:https://www.sciopen.com/article/10.26599/FSHW.2022.9250216
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841550164071809024
author Young-Jin Choi
Meiqi Fan
Nishala Erandi Wedamulla
Yujiao Tang
Eun-Kyung Kim
author_facet Young-Jin Choi
Meiqi Fan
Nishala Erandi Wedamulla
Yujiao Tang
Eun-Kyung Kim
author_sort Young-Jin Choi
collection DOAJ
description We evaluated the effect of isoquercetin (quercetin-O-3-glucoside-quercetin, IQ) as a functional component of Abeliophyllum disistichum Nakai ethanol extract (ADLE) on prostate cell proliferation and apoptosis and its effects on the IGF-1/PI3K/Akt/mTOR pathway in benign prostatic hyperplasia (BPH). Metabolites in ADLE were analyzed using UHPLC-qTOF-MS and HPLC. IQ was orally administered (1 or 10 mg/kg) to a testosterone propionate-induced BPH rat model, and its effects on the prostate weight were evaluated. The effect of IQ on androgen receptor (AR) signaling was analyzed in LNCaP cells. Whether IGF-1 and IQ affect the IGF-1/PI3K/Akt/mTOR pathway in BPH-1 cells was also examined. The metabolites in ADLE were identified and quantified, which confirmed that ADLE contained abundant IQ (20.88 mg/g). IQ significantly reduced the prostate size in a concentration-dependent manner in a BPH rat model, and significantly decreased the expression of AR signaling factors in the rat prostate tissue and LNCaP cells in a concentration-dependent manner. IQ also inhibited the PI3K/AKT/mTOR pathway activated by IGF-1 treatment in BPH-1 cells. In BPH-1 cells, IQ led to G0/G1 arrest and suppressed the expression of proliferation factors while inducing apoptosis. Thus, IQ shows potential for use as a pharmaceutical and nutraceutical for BPH.
format Article
id doaj-art-24da4e3644174882844fe8fa635edcc7
institution Kabale University
issn 2097-0765
2213-4530
language English
publishDate 2024-05-01
publisher Tsinghua University Press
record_format Article
series Food Science and Human Wellness
spelling doaj-art-24da4e3644174882844fe8fa635edcc72025-01-10T06:54:23ZengTsinghua University PressFood Science and Human Wellness2097-07652213-45302024-05-011331698171010.26599/FSHW.2022.9250216Alleviatory effect of isoquercetin on benign prostatic hyperplasia via IGF-1/PI3K/Akt/mTOR pathwayYoung-Jin Choi0Meiqi Fan1Nishala Erandi Wedamulla2Yujiao Tang3Eun-Kyung Kim4Department of Food Science and Nutrition, Dong-A University, Busan 49315, Republic of KoreaDivision of Food Bioscience, College of Biomedical and Health Sciences, Konkuk University, Chungju 27478, Republic of KoreaDepartment of Food Science and Nutrition, Dong-A University, Busan 49315, Republic of KoreaSchool of Bio-Science and Food Engineering, Changchun University of Science and Technology, Changchun 130600, ChinaNutritional Education Major, Graduate School of Education, Dong-A University, Busan 49315, Republic of KoreaWe evaluated the effect of isoquercetin (quercetin-O-3-glucoside-quercetin, IQ) as a functional component of Abeliophyllum disistichum Nakai ethanol extract (ADLE) on prostate cell proliferation and apoptosis and its effects on the IGF-1/PI3K/Akt/mTOR pathway in benign prostatic hyperplasia (BPH). Metabolites in ADLE were analyzed using UHPLC-qTOF-MS and HPLC. IQ was orally administered (1 or 10 mg/kg) to a testosterone propionate-induced BPH rat model, and its effects on the prostate weight were evaluated. The effect of IQ on androgen receptor (AR) signaling was analyzed in LNCaP cells. Whether IGF-1 and IQ affect the IGF-1/PI3K/Akt/mTOR pathway in BPH-1 cells was also examined. The metabolites in ADLE were identified and quantified, which confirmed that ADLE contained abundant IQ (20.88 mg/g). IQ significantly reduced the prostate size in a concentration-dependent manner in a BPH rat model, and significantly decreased the expression of AR signaling factors in the rat prostate tissue and LNCaP cells in a concentration-dependent manner. IQ also inhibited the PI3K/AKT/mTOR pathway activated by IGF-1 treatment in BPH-1 cells. In BPH-1 cells, IQ led to G0/G1 arrest and suppressed the expression of proliferation factors while inducing apoptosis. Thus, IQ shows potential for use as a pharmaceutical and nutraceutical for BPH.https://www.sciopen.com/article/10.26599/FSHW.2022.9250216isoquercetinbenign prostatic hyperplasiaandrogen receptor signalingpi3k/akt/mtor pathway
spellingShingle Young-Jin Choi
Meiqi Fan
Nishala Erandi Wedamulla
Yujiao Tang
Eun-Kyung Kim
Alleviatory effect of isoquercetin on benign prostatic hyperplasia via IGF-1/PI3K/Akt/mTOR pathway
Food Science and Human Wellness
isoquercetin
benign prostatic hyperplasia
androgen receptor signaling
pi3k/akt/mtor pathway
title Alleviatory effect of isoquercetin on benign prostatic hyperplasia via IGF-1/PI3K/Akt/mTOR pathway
title_full Alleviatory effect of isoquercetin on benign prostatic hyperplasia via IGF-1/PI3K/Akt/mTOR pathway
title_fullStr Alleviatory effect of isoquercetin on benign prostatic hyperplasia via IGF-1/PI3K/Akt/mTOR pathway
title_full_unstemmed Alleviatory effect of isoquercetin on benign prostatic hyperplasia via IGF-1/PI3K/Akt/mTOR pathway
title_short Alleviatory effect of isoquercetin on benign prostatic hyperplasia via IGF-1/PI3K/Akt/mTOR pathway
title_sort alleviatory effect of isoquercetin on benign prostatic hyperplasia via igf 1 pi3k akt mtor pathway
topic isoquercetin
benign prostatic hyperplasia
androgen receptor signaling
pi3k/akt/mtor pathway
url https://www.sciopen.com/article/10.26599/FSHW.2022.9250216
work_keys_str_mv AT youngjinchoi alleviatoryeffectofisoquercetinonbenignprostatichyperplasiaviaigf1pi3kaktmtorpathway
AT meiqifan alleviatoryeffectofisoquercetinonbenignprostatichyperplasiaviaigf1pi3kaktmtorpathway
AT nishalaerandiwedamulla alleviatoryeffectofisoquercetinonbenignprostatichyperplasiaviaigf1pi3kaktmtorpathway
AT yujiaotang alleviatoryeffectofisoquercetinonbenignprostatichyperplasiaviaigf1pi3kaktmtorpathway
AT eunkyungkim alleviatoryeffectofisoquercetinonbenignprostatichyperplasiaviaigf1pi3kaktmtorpathway